- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Uterine-sparing techniques are promising for managing adenomyosis with less risk of reintervention
In a systematic review published in Obstetrics & Gynecology by Liu et al. and team, researchers have said that Uterine-sparing techniques successfully manage adenomyosis and are associated with low reintervention rates.
Adenomyosis is a common benign gynecologic condition with a prevalence range of 20% to 34%. The incidence rises with age and peaks in ages 40–49 years. The condition is associated with painful menses, heavy menstrual bleeding, chronic pelvic pain, infertility, dyspareunia, and obstetric complications. The treatment usually includes medical therapy but has side effects and is also related to recurrence.
Adenomyomectomy, uterine artery embolization (UAE), and image-guided thermal ablation, including [high-intensity focused ultrasound (HIFU), radiofrequency ablation (RFA), and microwave ablation (MWA)]are the uterine-sparing interventions and are less common. These procedures improve adenomyosis symptoms and eliminate the hysterectomy need. However, more data should be available regarding the risks of recurrence and reintervention after these treatments.
Researchers said that considering the background of adenomyosis, more prone to relapse after treatment and in an attempt to provide valuable advice for clinical decision-making, we performed a systematic review and meta-analysis to evaluate recurrence and reintervention following uterine-sparing interventions.
The database searched were Web of Science, MEDLINE, Cochrane Library, EMBASE, ClinicalTrials.gov, and Google Scholar using relevant terms like “adenomyosis,” “recurrence,” “reintervention,” “relapse,” and “recur.”
The study results are:
- Forty-two studies represented 5,877 patients.
- Following adenomyomectomy, UAE, and image-guided thermal ablation, the recurrence rate was 12.6%, 29.5% and 10.0%, respectively.
- The reintervention rates were 2.6%, 12.8% and 8.2%, respectively.
They explained that in our review, we reported low rates of recurrence and reintervention rates for all uterine-sparing techniques.
Subgroup analyses revealed further improvement in recurrence and reintervention rates with adjuvant hormone therapy.
This indicates that medical adjuvant treatment may aid in providing longer, more durable symptom control than surgery alone.
Further investigations are warranted with a larger sample size.
Further reading:
Liu, Lu MD; Tian, Hongyan MM; Lin, Dongmei MM; Zhao, Liang MM; Wang, Hui MM; Hao, Yi MM. Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis: A Systematic Review and Meta-Analysis. Obstetrics & Gynecology 141(4):p 711-723, April 2023. | DOI: 10.1097/AOG.0000000000005080
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751